ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Obesity

Diabetes trials near Salt Lake City, UT, USA:

Phase 2 Spectra Study to Evaluate the Safety and Efficacy of OPL-0401 in Patients With Diabetic Retinopathy

OPL-0401-201 is a multicenter study to investigate the safety and efficacy of OPL-0401 in patients with diabetes mellitus (DM) with diabetic...

Active, not recruiting
Non-proliferative Diabetic Retinopathy
Proliferative Diabetic Retinopathy
Drug: Placebo
Drug: OPL-0401 Dose 1

Phase 2

Valo Health

Salt Lake City, Utah, United States of America and 24 other locations

New

randomized control study that will evaluate the safety and effectiveness of the embecta Automated Insulin Delivery System in adults with Type 2 diabetes...

Begins enrollment in 1 month
Type 2 Diabetes Mellitus (T2DM)
Type 2 Diabetes
Other: Standard of Care (SC)
Device: An AID System.
Embecta Corp.

Sandy, Utah, United States and 8 other locations

with vehicle control in subjects with Wagner Grade 1 to Grade 2 diabetic foot ulcers. Baseline target ulcer size (\<16 cm2 vs ≥16 cm2 ) will...

Enrolling
Diabetes Mellitus
Diabetic Foot Ulcer
Drug: ENERGI-F703 GEL
Drug: ENERGI-F703 matched vehicle

Phase 3

Energenesis Biomedical

Salt Lake City, Utah, United States of America and 20 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

sandy, Utah, United States of America and 49 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Enrolling
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Salt Lake City, Utah, United States and 19 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Salt Lake City, Utah, United States and 652 other locations

Locations recently updated

double-blind, parallel-group, placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD5004 in adults with type 2 diabetes...

Enrolling
Diabetes Mellitus, Type 2
Drug: AZD5004
Drug: Placebo (placebo matching AZD5004 film-coated tablet)

Phase 2

AstraZeneca
AstraZeneca

West Jordan, Utah, United States and 103 other locations

Study GR41675 is a Multicenter, Randomized Study in Participants with Diabetic Retinopathy (DR) Without Center-Involved Diabetic Ma...

Active, not recruiting
Diabetic Retinopathy
Drug: PDS Implant Pre-Filled with 100 mg/mL Ranibizumab
Drug: Intravitreal Ranibizumab 0.5 mg Injection

Phase 3

Roche
Roche

Salt Lake City, Utah, United States and 60 other locations

Pharmacokinetics and Pharmacodynamics of BMF-219, an Oral Covalent Menin Inhibitor, in Healthy Adult Subjects and in Adult Subjects with Type 2 Diabetes...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: BMF-219

Phase 1, Phase 2

Biomea Fusion

Jordan, Utah, United States and 43 other locations

This is a Phase 1, randomized, double-blind, placebo-controlled, first-in-human (FIH) study to evaluate the safety, tolerability, food effect (FE), p...

Enrolling
Type 2 Diabetes Mellitus
Drug: Placebo
Drug: XW014

Phase 1

Sciwind Biosciences

Salt Lake City, Utah, United States and 2 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems